Reduced Claudin-12 Expression Predicts Poor Prognosis in Cervical Cancer

Background: Within the claudin (CLDN) family, CLDN12 mRNA expression is altered in various types of cancer, but its clinicopathological relevance has yet to be established due to the absence of specific antibodies (Abs) with broad applications. Methods: We generated a monoclonal Ab (mAb) against hum...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahman, Abidur, Kobayashi, Makoto, Sugimoto, Kotaro, Endo, Yuta, Kojima, Manabu, Furukawa, Shigenori, Watanabe, Takafumi, Soeda, Shu, Hashimoto, Yuko, Fujimori, Keiya, Chiba, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038723/
https://www.ncbi.nlm.nih.gov/pubmed/33917356
http://dx.doi.org/10.3390/ijms22073774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038723/
https://www.ncbi.nlm.nih.gov/pubmed/33917356
http://dx.doi.org/10.3390/ijms22073774

Ejemplares similares